Intravenous Immunoglobulin (IVIg) Therapy
Antibodies, also known as immunoglobulins (Igs), are proteins produced by plasma cells and lymphocytes in human blood that are used to fight off infections caused by bacteria and viruses. Ig deficiency is caused by the person’s inability to produce antibodies as a result of illness or other factors. Some Ig deficiencies can be addressed through replacement therapies including intravenous immunoglobulin (IVIg) and subcutaneous (SCIg) therapies.
HPC provides specialty medications for several disease states, including branded IVIg and SCIg therapy products. Our comprehensive system of care includes pharmacy services for the specialized delivery of these products, skilled nurses trained in administering IVIg properly, and additional professional resources to help ensure the patients’ adherence to important therapy compliance in order to achieve the best outcomes.
IVIg and SCIg therapies provide important Ig replacement for antibody disorders, and help to provide protection from infection for immunosuppressed patients and those individuals with XLA, CVID, Hyper-IgM Syndromes, Wiskott Aldrich Syndrome or other forms of hypogammaglobulinemia. Depending upon physician orders, infusions of IVIg and SCIg therapies can be administered in an outpatient clinic, or in the patient’s home.
- Carimune® NF
Partnering for the Best Outcome
Improving the lives of patients includes the right treatments – and the right care. As a complete care pharmacy, HPC provides both. Our staff is comprised of knowledgeable, compassionate professionals who are qualified to support patients and their families and integrate care with the patients’ medical teams.
For more information on IVIg and SCIg treatment therapies and related conditions, please visit the following sites: